It has been proved that heparin-binding EGF-like growth factor (HB-EGF), an important ligand of epidermal growth factor receptor (EGFR), participates in tumorigenesis and development of ovarian cancer2 and also is a useful biomarker for cancer prognosis3,4. Here, EGFR is linked to cancer.